Q32 BiovsUnitedHealth

QTTB and UNH stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$346.10

Value $314B

+4.72%
UNH's page

Q32 Bio (QTTB) has a market value of $254M and UnitedHealth (UNH) $314B. Over the last year, with dividends, QTTB moved +300.5% and UNH +14.9%. The P/E is 7.9 for QTTB and 19.8 for UNH. Dividend yield: QTTB none, UNH 2.62%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    QTTB$254M

    UNH$314B

    UNH is 1,237 times QTTB

  • Revenue, 12 months

    QTTB$54M

    UNH$450B

    UNH is 8,368 times QTTB

  • Net income, 12 months

    QTTB$32M

    UNH$15.9B

    UNH is 492 times QTTB

  • Operating margin

    QTTB31.5%

    UNH5.3%

    26.2 points apart

  • ROIC

    QTTB31.8%

    UNH11.3%

    20.5 points apart

  • P/E

    QTTB7.9

    UNH19.8

    UNH is 2.5 times QTTB

  • Dividend yield

    QTTB0.0%

    UNH2.6%

    2.6 points apart

  • 5-year return

    QTTB-90.9%

    UNH-13.9%

    77.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

QTTB-90.9%

UNH-13.9%

05010015020222023202420252026
Returns by period
PeriodQTTBWith dividendsUNHWith dividends
1 year since November 19, 2025+300.5%Price +300.5%+14.9%Price +12.0%
3 years since November 20, 2023-15.0%-5.3% a yearPrice -15.0%-31.1%-11.7% a yearPrice -35.3%
5 years since November 19, 2021-90.9%-38.1% a yearPrice -90.9%-13.9%-2.9% a yearPrice -21.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

QTTBQ32 BioUNHUnitedHealth

Valuation

QTTBUNH
Valuation
Price$8.49$346.10
Market value$254M$314B
Enterprise value (EV)–$360B
P/E7.919.8
P/E, 5-year median–25.0
P/B0.93.0
EV/EBIT–15.0
Free cash flow yield–7.3%

Results and growth

QTTBUNH
Results and growth
Revenue, 12 months$54M$450B
Net income, 12 months$32M$15.9B
Free cash flow, 12 months-$20M$22.8B
Earnings per share, 12 months$1.08$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past+81.9%over 5 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

QTTBUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin31.5%5.3%
Net margin55.5%3.5%
ROIC31.8%11.3%
ROE34.8%15.5%

Balance sheet

QTTBUNH
Balance sheet
Cash$290M$28.5B
Total debt$8.6M$74.3B
Net debt / EBITDA-16.61.6
Interest cover–6.2×

Dividends and buybacks

QTTBUNH
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield–4.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: QTTB or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Q32 Bio or UnitedHealth?

By market value, UnitedHealth ($314B) is about 1,236.5 times Q32 Bio ($254M), at today's prices.

How did QTTB and UNH stock do over the last 5 years?

Since November 19, 2021, QTTB's price moved -90.9% and UNH's -21.4%. With dividends: QTTB -90.9% (-38.1% a year), UNH -13.9% (-2.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, QTTB or UNH?

The dividend yield at today's price is none for Q32 Bio and 2.62% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of QTTB and UNH?

At today's price, the P/E is 7.9 for QTTB and 19.8 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Q32 Bio or UnitedHealth?

Over the last twelve months, the net margin was 55.5% for Q32 Bio and 3.5% for UnitedHealth, and the operating margin 31.5% and 5.3%. Revenue was $54M and $450B.

Which is the better investment, Q32 Bio or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.